tradingkey.logo

Elevance Health Inc

ELV
318.600USD
-3.350-1.04%
Horário de mercado ETCotações atrasadas em 15 min
70.74BValor de mercado
12.79P/L TTM

Elevance Health Inc

318.600
-3.350-1.04%

Mais detalhes de Elevance Health Inc Empresa

Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefit, CarelonRx, Carelon Services, and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to Individual, employer group risk-based, employer group fee-based, BlueCard, Medicare, Medicaid and federal employees health benefits (FEHB) program members. The CarelonRx segment includes its pharmacy business. CarelonRx markets and offers pharmacy services to affiliated health plan customers, as well as to external customers outside of the health plans. It also offers infusible and injectable therapies. Carelon Services offers healthcare-related services and capabilities to internal and external customers including integrated care delivery, behavioral health, palliative care, utilization management, payment integrity services and subrogation services, as well as health and wellness programs.

Informações de Elevance Health Inc

Código da empresaELV
Nome da EmpresaElevance Health Inc
Data de listagemOct 30, 2001
CEOMs. Gail K. Boudreaux
Número de funcionários103158
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 30
Endereço220 Virginia Avenue
CidadeINDIANAPOLIS
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal46204
Telefone18003311476
Sitehttps://www.elevancehealth.com/
Código da empresaELV
Data de listagemOct 30, 2001
CEOMs. Gail K. Boudreaux

Executivos da empresa Elevance Health Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.35K
+6.87%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.92K
+13.90%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.79K
+14.35%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
1.69K
+3.99%
Ms. Deanna D. Strable-Soethout
Ms. Deanna D. Strable-Soethout
Independent Director
Independent Director
1.65K
+57.51%
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Independent Director
Independent Director
639.00
--
Mr. Robert L. Dixon, Jr.
Mr. Robert L. Dixon, Jr.
Independent Director
Independent Director
--
--
Mr. Mark B. Kaye
Mr. Mark B. Kaye
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Ratnakar V. Lavu
Mr. Ratnakar V. Lavu
Executive Vice President and Chief Digital Information Officer
Executive Vice President and Chief Digital Information Officer
--
--
Ms. Gail K. Boudreaux
Ms. Gail K. Boudreaux
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.35K
+6.87%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.92K
+13.90%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.79K
+14.35%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
1.69K
+3.99%
Ms. Deanna D. Strable-Soethout
Ms. Deanna D. Strable-Soethout
Independent Director
Independent Director
1.65K
+57.51%
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Independent Director
Independent Director
639.00
--

Detalhamento da receita

FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Premiums
41.27B
0.00%
Product revenue
6.04B
0.00%
Service fees
2.11B
0.00%
Reconciliation
355.00M
0.00%
Operating revenue - affliated
0.00
0.00%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Premiums
41.27B
0.00%
Product revenue
6.04B
0.00%
Service fees
2.11B
0.00%
Reconciliation
355.00M
0.00%
Operating revenue - affliated
0.00
0.00%

Distribuição de ações

Atualizado em: dom, 26 de out
Atualizado em: dom, 26 de out
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
10.24%
BlackRock Institutional Trust Company, N.A.
5.23%
State Street Investment Management (US)
4.76%
T. Rowe Price Associates, Inc.
3.49%
Capital International Investors
2.92%
Outro
73.37%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
10.24%
BlackRock Institutional Trust Company, N.A.
5.23%
State Street Investment Management (US)
4.76%
T. Rowe Price Associates, Inc.
3.49%
Capital International Investors
2.92%
Outro
73.37%
Tipos de investidores
Investidores
Proporção
Investment Advisor
52.91%
Investment Advisor/Hedge Fund
31.90%
Bank and Trust
2.47%
Pension Fund
2.44%
Research Firm
2.01%
Hedge Fund
1.73%
Sovereign Wealth Fund
1.42%
Family Office
0.27%
Family Office
0.27%
Outro
4.59%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
3047
209.27M
92.93%
-7.67M
2025Q2
3093
215.32M
95.62%
-4.57M
2025Q1
3135
209.98M
92.91%
-9.57M
2024Q4
3098
213.30M
93.78%
-5.08M
2024Q3
3004
212.78M
91.75%
-6.27M
2024Q2
2973
214.50M
92.28%
-4.31M
2024Q1
2940
212.64M
91.38%
-6.83M
2023Q4
2879
214.42M
91.26%
-6.60M
2023Q3
2767
215.95M
91.62%
-5.63M
2023Q2
2750
218.40M
92.12%
-4.32M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
22.75M
10.1%
-140.75K
-0.61%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
11.62M
5.16%
-183.35K
-1.55%
Jun 30, 2025
State Street Investment Management (US)
10.57M
4.69%
-78.72K
-0.74%
Jun 30, 2025
T. Rowe Price Associates, Inc.
7.75M
3.44%
-1.01M
-11.48%
Jun 30, 2025
Capital International Investors
6.49M
2.88%
+932.14K
+16.78%
Jun 30, 2025
Wellington Management Company, LLP
6.32M
2.81%
+523.40K
+9.03%
Jun 30, 2025
Sanders Capital, LLC
5.83M
2.59%
+1.15M
+24.66%
Jun 30, 2025
Geode Capital Management, L.L.C.
5.09M
2.26%
-72.83K
-1.41%
Jun 30, 2025
Artisan Partners Limited Partnership
3.68M
1.63%
+324.40K
+9.68%
Jun 30, 2025
First Eagle Investment Management, L.L.C.
3.20M
1.42%
-41.22K
-1.27%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: seg, 6 de out
Atualizado em: seg, 6 de out
Nome
Proporção
iShares U.S. Healthcare Providers ETF
9.06%
Monarch Dividend Plus Index ETF
3.38%
GMO US Quality ETF
2.36%
First Trust Total US Market AlphaDEX ETF
2.2%
Monarch Volume Factor Dividend Tree Index ETF
2.17%
T Rowe Price Equity Income ETF
1.88%
John Hancock Fundamental All Cap Core ETF
1.84%
iShares Large Cap Value Active ETF
1.71%
VictoryShares Free Cash Flow ETF
1.64%
Bushido Capital US Equity ETF
1.63%
Ver Mais
iShares U.S. Healthcare Providers ETF
Proporção9.06%
Monarch Dividend Plus Index ETF
Proporção3.38%
GMO US Quality ETF
Proporção2.36%
First Trust Total US Market AlphaDEX ETF
Proporção2.2%
Monarch Volume Factor Dividend Tree Index ETF
Proporção2.17%
T Rowe Price Equity Income ETF
Proporção1.88%
John Hancock Fundamental All Cap Core ETF
Proporção1.84%
iShares Large Cap Value Active ETF
Proporção1.71%
VictoryShares Free Cash Flow ETF
Proporção1.64%
Bushido Capital US Equity ETF
Proporção1.63%

Dividendo

Um total de 6.19B USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Jan 23, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Mar 25, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 25, 2025
Mar 10, 2025
Oct 17, 2024
ELV.NB Final Cash Dividend of gross USD 1.63 paid on Dec 20, 2024 going ex on Dec 05, 2024
Dec 05, 2024
Dec 20, 2024
Dec 05, 2024
Jul 17, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Sep 25, 2024 going ex on Sep 10, 2024
Sep 10, 2024
Sep 25, 2024
Sep 10, 2024
Apr 18, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Jun 25, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 25, 2024
Jun 10, 2024
Jan 26, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Mar 22, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 22, 2024
Mar 07, 2024
Oct 18, 2023
ELV.NB Final Cash Dividend of gross USD 1.48 paid on Dec 21, 2023 going ex on Dec 05, 2023
Dec 06, 2023
Dec 21, 2023
Dec 05, 2023
Jul 19, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Sep 22, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 22, 2023
Sep 07, 2023
Apr 19, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Jun 23, 2023 going ex on Jun 08, 2023
Jun 09, 2023
Jun 23, 2023
Jun 08, 2023
Jan 25, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Mar 24, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 24, 2023
Mar 09, 2023
Oct 19, 2022
ELV.NB Final Cash Dividend of gross USD 1.28 paid on Dec 21, 2022 going ex on Dec 02, 2022
Dec 05, 2022
Dec 21, 2022
Dec 02, 2022
Ver Mais

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI